GEM 21A

Details for Australian Trade Mark No. 1035856 (hide)

Owner BioMimetic Therapeutics, Inc.

IR Number 838077

Filing Date 4 November 2004

Classes

Class 5 Growth factor enhanced pharmaceutical preparations which include bone allograft material for the treatment of 1) bone and soft tissue defects in a wide range of indications such as periodontal, cranio-maxillofacial head, jaw, and face), osteoporotic, sports medicine, other orthopedic applications, and 2) related wound healing and tissue repair

Event Publications

13 January 2005 Application filed

17 March 2005 Application Accepted

14 July 2005 Trade Mark Registered/Protected

9 October 2008 Subsequent Owners/Holder Registered - Full Assignment

  BioMimetic Therapeutics, Inc. is the full asignee of Luitpold Pharmaceuticals, Inc..

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1035857-CORE

1035855-GEM OS